Vilon

Published · Researched 2026-09-21

Overview

Vilon (also sold as "KE" peptide) is a synthetic dipeptide of L-lysine and L-glutamic acid (Lys-Glu), one of the shortest peptide bioregulators from Professor Vladimir Khavinson's research program at the St. Petersburg Institute of Bioregulation and Gerontology (1970s–2000s). The proposed mechanism is direct chromatin interaction in thymus-derived immune cells — deheterochromatinization modulating gene expression (cytokine regulation, T-cell homeostasis), with published work including SIRT1 upregulation / PARP1/PARP2 downregulation in human mesenchymal stem cells (2023) and mouse lifespan/tumor-prevalence studies (2000). Distinct from the other two items in this track: Vilon is a registered pharmaceutical drug in Russia (Vilon nasal spray / "Normoftal" synonym listed in pharma contexts), while outside Russia it is sold as an unregulated research chemical, typically 10 mg and 20 mg lyophilized vials.

Social standing

Overall pulse: small but real; infographic-driven, not discussion-driven. Vilon has a genuine niche footprint in the longevity/bioregulator corner of the biohacker community, but the conversation is dominated by brand/educator infographics rather than owner experience threads.

Platform-by-platform:

  • Instagram (dominant): The bulk of signal is polished infographic carousels and reels: Driven Ones (@drivenonesllc) multi-part Vilon series (Sept 2026) — dipeptide identity, thymus/immune framing, research history 1970s–2022; The Peptide Company Khavinson Bioregulator Series (July 2026, 5 peptides/5 organs); Peptiva/Peptix bilingual infographics; Peptara Labs carousel (Sept 2026) — the most evidence-honest source, noting lifespan extension and tumor prevention in normal CBA mice BUT increased mammary tumors in cancer-prone transgenic mice, with no human RCTs and no independent replication; @OptimalNathan (X-screenshot carousels reposted to IG, July 2026 — 96 likes, 5 comments) pushing the epigenetic "goes straight to the gene" narrative (KE binds GCGC sequences in 642 gene promoters; SIRT1/PARP study, 2023), with comments asking where to buy and one safety counterpoint ("the Russian inventor died prematurely from toxicity" — UNVERIFIED anecdote, no verbatim quote captured). Product promos: Kidney Coach Official promoting UK-PEPTIDES.COM Vilon 20 mg; SHUQI "VILON 20MG" promo reel.
  • Facebook (thin): A handful of reels: high-production 3D explainers ("Two amino acids. The smallest molecule in the Khavinson catalog... signals bone marrow"); a DrivenOnes-style slideshow. No substantive group discussion threads found — the Peptide Pioneers-type groups surfaced in search did not yield Vilon-specific threads. Flagged as weak.
  • Threads: no Vilon-specific content found. Flagged as absent.

Viral moments: none identified; the largest single Vilon post observed was an Action Junkeez podcast clip (~1.9K likes) about Khavinson/Epithalon more broadly, not Vilon specifically. Vilon rides the Epithalon/bioregulator wave rather than generating its own.

Recurring praise: longevity/immune-aging framing, thymus support, "shortest bioregulator," epigenetic mechanism storytelling, oral/sublingual viability (PepT1 transporter arguments from Optimal Nathan).

Recurring complaints / failure modes: (1) evidence limited to Russian-source preclinical data, no human RCTs, sparse Western replication (Peptara Labs evidence tier); (2) the transgenic-mouse mammary tumor signal flagged by the most honest vendor-educator; (3) wild dosing inconsistency across sources (mcg sublingual vs. mg injections — see specs); (4) vendor label inconsistencies (wrong MW/CAS on some vendor pages — see UNVERIFIED section); (5) toxicity rumor in comments, unverifiable.

Representative quotes (attributed): No verbatim owner/user quotes were found — Vilon discussion is overwhelmingly infographic/vendor content with minimal user commentary. This absence is itself a signal (see verdict). One paraphrased safety counterpoint appeared on @OptimalNathan's July 2026 carousel: a commenter warned that the Russian inventor died prematurely from toxicity — UNVERIFIED anecdote, no verbatim text captured.

Social validation

Tier 3 — flagged: evidence is essentially single-platform (Instagram infographics/reels from brands and educator accounts) with only thin Facebook reel coverage and no Threads or Facebook-group discussion found. No owner-experience threads to validate real-world use.

Named sources and what each proves:

Key specs table

Property Value
Amino acid sequence H-Lys-Glu-OH (Lys-Glu, "KE" dipeptide)
Molecular weight 275.30 g/mol (consensus). Conflicting: Umbrella Labs and BiotechPeptides list 257.30 g/mol; peptide-powder.com lists CAS 162758-68-1. Flagged as vendor-page inconsistencies — UNVERIFIED
Molecular formula C11H21N3O5
CAS 45234-02-4 (most listed; PubChem CID 7010502). Conflicting entry noted above
Mechanism (as studied) Proposed direct chromatin interaction in thymic cells (deheterochromatinization); KE binding to GCGC promoter sequences; SIRT1 upregulation / PARP1/2 downregulation in human MSCs (2023); lymphocyte apoptosis inhibition; interferonogenesis/NK-cell stimulation at low doses in animal work
Available forms Research vials 10 mg / 20 mg (standard gray-market); Russian pharma nasal spray (approved drug in Russia only); oral capsules (e.g., RegenMed bioregulator complex); sublingual/intranasal community protocols
Community-reported dosing (OBSERVED only, UNVERIFIED — ranges conflict wildly) peptides.org sample: 5 mg SC/day × 12 days, repeat every 4–6 months; muscleandbrawn/Swiss Chems: 5 mg SC/day × 7–12 days; thepeptidetoolkit: 100–200 mcg SC; wikipep: 10–20 mcg sublingual daily × 10–20 days; Khavinson protocol: 10 mcg + Epithalon; fightaging self-experiment: 10 mg SC × 10 days/month. No consensus; all anecdotal or vendor-suggested

Note on naming confusion: one social source labeled Vilon as "Cys-Arg-Lys-Gly-Asp" — this conflicts with the Lys-Glu dipeptide consensus across vendor spec sheets and literature; flagged as likely creator error, not adopted.

Pricing (observed 2026-09-20)

  • Umbrella Labs — 10 mg vial, ≥99% LC-MS: $35.00 (https://umbrellalabs.is/shop/peptides/peptide-vials/vilon/, observed 2026-09-20)
  • Swiss Chems — 20 mg vial: $63 (via muscleandbrawn.com/peptides/vilon-essential-insights-on-benefits/, observed 2026-09-20)
  • Third-party COAs observed: Orbitrex Peptides Vilon 20 mg (FreedomDiagnostics, lot VI20826, July 2026 — purity ~99.42–99.43%, net content 23.74–24.97 mg); PeptideSupplyCo Vilon 20 mg (FreedomDiagnostics, June 2026 — ~99.28–99.33%) (https://orbitrexpeptide.is/coas/vilon-20mg-vi20826/2026-07-26)
  • Typical street range per vendor listings: ~$30–60 for 10–20 mg (range from observed listings, not a survey — UNVERIFIED)
  • Facebook Marketplace used-range: none observed for Vilon.

What's included / what's needed

  • Included: one lyophilized Vilon vial (10 mg or 20 mg), typically with COA link.
  • Russian pharma version: nasal spray formulation (approved drug in Russia only) — a distinct product from the research vials.
  • Needed for vial form (per community practice, reported neutrally): bacteriostatic water, sterile syringes, alcohol wipes; vendor storage guidance ranges from "do NOT freeze, refrigerate" to −20 °C long-term — inconsistent across vendors, flagged.

Support reality

  • Vendor support reputation: thin data; Vilon is a low-volume SKU with little community review traffic. Product pages position it as premium/longevity (Swiss Chems, Modern Aminos "US-made, 3rd-party tested").
  • Counterfeit/fake concerns: moderate — no major fake-Vilon scandals surfaced, but the broader research-peptide counterfeit concern applies; third-party COAs exist (FreedomDiagnostics for Orbitrex, PeptideSupplyCo).
  • COA/third-party testing discussion: present at vendor level (COAs published); no community-run testing or group vetting threads found for Vilon specifically.

Community verdict

Vilon is a genuine but niche corner of the bioregulator world: the Khavinson lineage and the dipeptide's epigenetic story (SIRT1/PARP data, chromatin interaction) give it real intellectual scaffolding, and Russian pharma registration sets it apart from pure research chemicals — but the Western social footprint is almost entirely vendor/educator infographics, not owner experience, and the most honest vendor-educator (Peptara Labs) flags both the transgenic-mouse tumor signal and the absence of human RCTs. Wildly inconsistent dosing across sources (10 mcg to 10 mg) and vendor label errors (MW/CAS discrepancies) mean buyers should treat every spec as unverified.

Regulatory & safety status

  • Not an FDA-approved drug. Sold outside Russia as a research chemical "for research use only / not for human consumption." Within Russia, Vilon is a registered pharmaceutical (nasal spray; synonyms include Normoftal/lysylglutamate per vendor pharma references) — approved drug in Russia only.
  • Safety signals (observed data): generally described as well tolerated in vendor materials (rare mild fatigue, minimal injection-site discomfort per muscleandbrawn); Peptara Labs' evidence summary notes lifespan extension and reduced spontaneous tumors in normal CBA mice but increased mammary tumors in cancer-prone transgenic mice — a real, published caution signal; an unverifiable comment-level rumor about inventor toxicity exists and is explicitly UNVERIFIED. No validated human dosing.

Image view breakdown

5/8 obtained. All real vendor/retailer photos, converted to JPEG, saved under img/:

  • hero: vilon-hero.jpg — peptide.cn.com Vilon 20 mg vial photo (peptide.cn.com)
  • side: vilon-side.jpg — Certa Peptides Vilon 20 mg product photo (certapeptides.com)
  • detail: vilon-detail.jpg — Purity Peptides Vilon 20 mg product image (puritypeptides.is)
  • box: vilon-box.jpg — Core Peptides Vilon 20 mg product shot (corepeptides.com)
  • top: vilon-top.jpg — LA Peptides Vilon 20 mg vial photo (lapeptides.net)

Missing views (honestly not obtainable): rear, inuse (no real owner in-use photos surfaced), scale. No true packaging/kit photo was obtainable; the "box" slot holds a distinct vendor product shot. A Russian-pharma nasal-spray image search returned candidates (zibero.ru, youmarket.shop) but none passed a confident product-verification threshold, so no pharma-packaging image was kept — flagged rather than substituted.

Not medical advice. This is a research summary of publicly discussed information, not a recommendation to use any substance.

Vilon — box view
box view Original vendor page URL not recorded in research dossier
Vilon — detail view
detail view Original vendor page URL not recorded in research dossier
Vilon — hero view
hero view Original vendor page URL not recorded in research dossier
Vilon — side view
side view Original vendor page URL not recorded in research dossier
Vilon — top view
top view Original vendor page URL not recorded in research dossier

Sources